Skip to main content

Masson-Hurlburt Elizabeth's Form 4 filing

CorMedix Inc. (CRMD) · filed Sep 11, 2025

Accession no.
0001213900-25-087013
Filed
Sep 11, 2025
Trade date
Sep 9-11, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $711.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Masson-Hurlburt ElizabethCIK 0001735256Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 9, 2025Common StockMOption exerciseAcquired+12,876$1.45+$18,670.2189,866Direct
Sep 9, 2025Common StockSSaleDisposed−12,876$13.51F1−$173,954.76176,990Direct
Sep 11, 2025Common StockMOption exerciseAcquired+41,121$1.45+$59,625.45218,111Direct
Sep 11, 2025Common StockSSaleDisposed−41,121$13.08F2−$537,862.68176,990Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 9, 2025Common StockMOption exerciseDisposed−12,876$0.00$041,121Direct
Sep 11, 2025Common StockMOption exerciseDisposed−41,121$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F2

This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)